CORLIEVE THERAPEUTICS
Corlieve Therapeutics is a biotechnology company focused on bringing novel therapeutic options to patients with severe neurological disorders.
CORLIEVE THERAPEUTICS
Industry:
Biotechnology Health Care
Founded:
2019-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.corlieve.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Font Awesome Nginx Euro Microsoft Exchange Online
Similar Organizations
Callitas Therapeutics
Callitas Therapeutics is a Biotechnology company.
Rekindle Therapeutics
Rekindle Therapeutics is a biotechnology company.
RNADerm Therapeutics
RNADerm Therapeutics is a biotechnology company.
Telum Therapeutics
Telum Therapeutics is a biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Kinled Holding
Kinled Holding investment in Seed Round - Corlieve Therapeutics
Kurma Partners
Kurma Partners investment in Seed Round - Corlieve Therapeutics
Pureos Bioventures
Pureos Bioventures investment in Seed Round - Corlieve Therapeutics
Idinvest Partners
Idinvest Partners investment in Seed Round - Corlieve Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-22 | Rewind Therapeutics appoints Anja Harmeier, PhD, MBA, as Chief Executive Officer |
Official Site Inspections
http://www.corlieve.com
- Host name: fw01.pcx-ams03.provider.nl
- IP address: 185.87.184.231
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "Corlieve Therapeutics"
Corlieve Therapeutics - Crunchbase Company Profile & Funding
Corlieve Therapeutics may be growing as indicated by recent strategic movements in the biotechnology and health care industry. The company has been acquired by uniQure, which …See details»
Corlieve Therapeutics
Corlieve’s Leadership Team, Board Members and Advisors provide expertise and a passion for pursuing novel scientific approaches in neuroscience, epilepsy, gene therapy, and building …See details»
uniQure to Acquire Corlieve Therapeutics and Advance
Jun 22, 2021 Corlieve Contacts: Amy Conrad Juniper Point 858-366-3243 [email protected] Or [email protected]. uniQure Contacts: FOR INVESTORS: ...See details»
Corlieve Therapeutics - LinkedIn
Corlieve Therapeutics, a fully owned subsidiary of UniQure, is a biotechnology company focused on bringing novel therapeutic options to patients with severe neurological disorders.See details»
uniQure to Acquire Corlieve Therapeutics and Advance its Gene …
Jun 22, 2021 Lexington, MA; Amsterdam, the Netherlands; and Paris, France, June 22, 2021 — uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative …See details»
UniQure to Acquire Corlieve Therapeutics and Advance its Gene …
Corlieve has an established license and collaboration agreement with REGENXBIO that includes an exclusive license to AAV9 for the specific genetic target of AMT-260. Under the license and …See details»
uniQure to Acquire Corlieve Therapeutics and Advance its Gene …
Jun 22, 2021 AMT-260 was originally developed by Corlieve in collaboration with Christophe Mulle, Ph.D., CNRS Research Director, at the Interdisciplinary Institute of Neurosciences, …See details»
Corlieve Therapeutics - Products, Competitors, Financials, …
Corlieve Therapeutics is a biotechnology company that aims to bring therapeutic options to patients with severe neurological disorders. On June 22nd, 2021, Corlieve Therapeutics was …See details»
uniQure Expands Neurological Gene Therapy Pipeline With …
Jun 23, 2021 “The acquisition of Corlieve provides an extraordinary opportunity to transform the lives of hundreds of thousands of patients around the world suffering from epilepsy and aligns …See details»
Corlieve Therapeutics - Company Profile - Tracxn
Nov 21, 2024 Corlieve Therapeutics ranks 249th among 567 active competitors. 211 of its competitors are funded while 138 have exited. Overall, Corlieve Therapeutics and its …See details»
uniQure to Acquire Corlieve Therapeutics - Bordeaux Neurocampus
Jul 1, 2021 Source: press release. uniQure N.V.(NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today …See details»
After rebounding from FDA setback, uniQure goes all in on gene …
Jun 22, 2021 As part of the uniQure deal, Corlieve will also receive up to 43.7 million euros ($52.1 million) for development milestones through phase 1/2 and another 160 million euros …See details»
Home - Pureos Bioventures
Corlieve Therapeutics. Corlieve Therapeutics is a French biotech company, developing transformational therapies for neurological diseases. The lead program is a treatment for drug …See details»
Corlieve Therapeutics - Overview, News & Competitors - ZoomInfo
Corlieve Therapeutics was founded in November 2019 with a singular purpose of bringing novel therapeutic options to patients with severe neurological disorders. The founders Richard …See details»
Corlieve Therapeutics - Contacts, Employees, Board Members, …
Organization. Corlieve Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News ... Employee Profiles 1. Number of Board Member and Advisor …See details»
Morgan Lewis Advises uniQure on Acquisition of Corlieve …
Jun 22, 2021 Morgan Lewis has advised uniQure N.V., a leading gene therapy company, on its agreement to acquire Corlieve Therapeutics, a private French biotech company. Corlieve’s …See details»
Corlieve Therapeutics - EU-Startups
Corlieve Therapeutics is a biotechnology company based in Paris, France. They develop medicines for specific neuronal targets that can transform patients’ lives. The company …See details»
Corlieve Therapeutics Company Information - Funding, Investors, …
Jan 1, 2020 Corlieve Therapeutics https://corlieve.com. Biotechnology company focused on developing gene therapies for neurological disorders. GET THE TOP 10 COMPANIES OF …See details»
uniQure to Acquire Corlieve Therapeutics and Advance its Gene …
Jun 22, 2021 These forward-looking statements include, but are not limited to, whether uniQure or Corlieve will advance the AMT-260 program to the clinic rapidly or at all, and whether the …See details»
Corlieve Therapeutics SAS closes seed financing to develop …
Corlieve Therapeutics today announced the closing of its seed financing led by Kurma Partners and IDinvest Partners, together with Pureos Bioventures. Corlieve is focused on developing …See details»